# OnCo record x4-pharmaceuticals (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/x4-pharmaceuticals/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "x4-pharmaceuticals" ;
  schema:name "X4 Pharmaceuticals"@en ;
  schema:alternateName "X4 Pharmaceuticals, Inc."@en, "NASDAQ:XFOR"@en ;
  schema:description "X4 Pharmaceuticals is a Boston biotech whose oral CXCR4 blocker mavorixafor won approval as Xolremdi for WHIM syndrome and is being tested to free neutrophils in chronic neutropenia and to open tumours to immune attack."@en ;
  schema:url <https://onco.cc/companies/x4-pharmaceuticals/>, <https://www.x4pharma.com/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.x4pharma.com/> ;
  onco:tag "drug-maker" ;
  schema:addressCountry "US" ;
  onco:drugs <https://onco.cc/drugs/mavorixafor/> .